Is Delek US Holdings Inc (DK) One of the Beat Oil and Gas Refinery Stocks to Buy Now?
Delek US Holdings Inc (NYSE:DK) is among the best oil & gas refinery stocks to buy now. On February 18, Delek US Holdings Inc (NYSE:DK) announced that it plans to pay a quarterly dividend of $0.255 per share on March 9. This announcement came as the company prepares to release its Q4 2025 results on February 27.
In its Q3 2025 report, which was released in November, Delek posted adjusted EPS of $7.13. Wall Street was expecting it to report a loss per share of $0.09. Revenue of $2.89 billion rose from $3.04 billion in the same quarter in 2024 and surpassed $2.7 billion that was expected. The quarter was buoyed by $280.8 million in benefits tied to Small Refinery Exemptions granted by the U.S. Environmental Protection Agency.
On January 27, Morgan Stanley restated its Equal Weight rating on Delek stock but lowered the price target to $38 from $40. This action was driven by valuation reassessment as the firm pointed out that refining stocks had soared following the events in Venezuela. That said, Morgan Stanley remains constructive on the long-term outlook of refining companies.
Delek US Holdings Inc (NYSE:DK), based in Brentwood, TN, is a diversified energy company. Its specialties are petroleum refining, with operations strategically located in places like Krotz Springs, Louisiana, Tyler and Big Spring, Texas, and El Dorado, Arkansas. The company also runs renewable fuels, asphalt, and logistics businesses.
While we acknowledge the potential of DK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Angel Oak: Fourth Quarter Financial Results Overview
Dyne Therapeutics to Participate in Upcoming Investor Conferences

Starwood Property Trust: Fourth Quarter Earnings Overview

